In Diagnostic agent Ultravist 0.623gm Infusion contains a radiopaque contrast medium indicated for radiographic examination before an x-ray or CT-scan. It helps for better visualisation of the parts where it is injected by a radiologist or a nurse and helps in diagnosing problems in the inside areas that are not visible to the naked eyes. This enables to diagnose the underlying problem and helps to treat you better.
It is not known whether it is safe to consume alcohol with Ultravist 0.623gm Infusion. Please consult your doctor.
Ultravist 0.623gm Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Ultravist 0.623gm Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether Ultravist 0.623gm Infusion alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Ultravist 0.623gm Infusion should be used with caution in patients with severe kidney disease. Dose adjustment of Ultravist 0.623gm Infusion may be needed. Please consult your doctor.
Ultravist 0.623gm Infusion should be used with caution in patients with severe liver disease. Dose adjustment of Ultravist 0.623gm Infusion may be needed. Please consult your doctor.
Not applicable. Ultravist 0.623gm Infusion is given before imaging test, so it is important to take it at the time as advised by the doctor. If you miss the dose, your test results can be inaccurate.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More